Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$2.1 - $3.36 $237,711 - $380,338
-113,196 Reduced 3.22%
3,403,276 $7.86 Million
Q2 2022

Aug 12, 2022

SELL
$4.27 - $8.26 $896,699 - $1.73 Million
-210,000 Reduced 5.64%
3,516,472 $15.9 Million
Q1 2022

May 13, 2022

SELL
$7.07 - $11.62 $11.3 Million - $18.6 Million
-1,600,000 Reduced 30.04%
3,726,472 $29.9 Million
Q3 2021

Nov 12, 2021

BUY
$9.94 - $12.77 $52.9 Million - $68 Million
5,326,472 New
5,326,472 $66 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.